Medication Can't Do It All, Says Obesity and Weight Management Expert

News
Video

"These [antiobesity] agents are meant to be used to help patients with a healthy lifestyle. They work best and long-term if patients also receive education on the essentials of a healthy diet and physical activity."


In a recent conversation with Patient Care,® obesity and weight management expert Caroline Apovian, MD, emphasized for primary care clinicians that GLP-1 receptor agonists when used for chronic weight management should be paired with patient counseling for an optimal outcome.

Caroline M Apovian, MD, is a professor of medicine a Harvard Medical School and codirector of the Center for Weight Management and Wellness in the division of endocrinology, diabetes, and hypertension at Brigham and Women's Hospital in Boston, MA. Apovian is one of the founding creators of the American Board of Obesity Medicine, the body that provides certification and recognition for physicians who have specialized knowledge and training in the practice of obesity medicine.


Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
© 2025 MJH Life Sciences

All rights reserved.